A Double-Blind Controlled Subjective Study of a New Pharmaceutical Preparation of Lormetazepam versus Placebo in Patients with Chronic Sleep Disturbances
Restricted accessResearch articleFirst published online January, 1985
A Double-Blind Controlled Subjective Study of a New Pharmaceutical Preparation of Lormetazepam versus Placebo in Patients with Chronic Sleep Disturbances
A double-blind crossover trial was carried out on the sleep-inducing activity of a new preparation (oral drops) of lormetazepam versus placebo. Twenty patients were included and requested to subjectively evaluate their sleep, both by analogue scales and semiquantitative ratings, during 2-night administration of the two products.
Also, the usual parameters, sleep duration, sleep latency and number of awakenings were evaluated.
Lormetazepam drops appeared to exert the same actions as the capsules' preparation, being significantly different from those of the placebo.
Get full access to this article
View all access options for this article.
References
1.
CasacchiaMBoniBDi MuccioL (1982) Lormetazepam nei disturbi del sonno: studio in doppio cieco crossover versus flunitrazepam. In: a cura di De Maio D et al: Il sonno e Insonnie, Roma, Antonio Delfino Editore, 87–93.
2.
CeccarelliGCiampiniMMichettiF (1984) Il lormetazepam come esempio di farmaco ipnoinducente: nuovi dati e problematiche. 1st Congress of the Mediterranean Society of Therapy, 10–15 Giugno, Firenze.
3.
De MaioD (1982) Recenti acquisizioni sulle benzodiazepine. In: De Maio, lc, 65–75.
4.
De MaioDLevi-MinziABiasioL R (1982) Risultati di una prova clinica condotta con il lormetazepam in una popolazione psichiatrica ospedalizzata. In: De Maio, lc, 77–85.
5.
DorowR GSeidlerJSchneiderH H (1982) A radioreceptor assay to study the affinity of benzodiazepines and their receptor binding activity in human plasma including their active metabolites. British Journal of Clinical Pharmacology13, 561.
6.
FraschiniF (1985) Biodisponibilità del lormetazepam nell'uomo: confronto delle formulazioni in gocce e in compresse. Personal Communication (in press).
7.
GuilleminaultC (1984) Benzodiazepine: effetti sul sonno e sulla capacità di attenzione del giorno successivo. Studio a lungo termine dopo somministrazione di lormetazepam e flurazepam. Clinica Terapeutica109, (3), 231.
8.
HeidrichHOttHBeachR C (1981) Lormetazepam. A benzodiazepine derivative without hangover effect? A double-blind study with chronic insomniacs in a general practice setting. International Journal of Clinical Pharmacology, Therapeutics and Toxicology19, (1), 11.
9.
HümpelMIlliVMiluisW (1979) The pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in humans I. Absorption, distribution, elimination and metabolism of lormetazepam. 5–14 C. European Journal of Drug Metabolism and Pharmacokinetics (4), 237.
10.
NicolettiFCostanzoE (1982) Effetto ipnoinducente di due benzodiazepine: studio controllato in doppia cecità. In: De Maio, lc, 99–104.
11.
OttH (1982) Why a new benzodiazepine? Clinical and therapeutic aspects of lormetazepam (Noctamid). In: Lormetazepam/Noctamid. A New Generation Hypnotic. ScheringAG ed. (ISBN 3-921817-11-0), 87–96.
12.
PaciAOttavianoPBiasioL R (1982) Risultati di un'esperienza policentrica ambulatoriale nel trattamento dell'insonnia con lormetazepam. In: De Maio, lc, 143–51.
13.
RapisardaVVirzi‘AMichettiF (1982) Risultati di uno studio clinico con due nuove benzodiazepine. In: De Maio, lc, 113–21.
